Efficacy of first-line treatment options in advanced HER2-altered non-small cell lung cancer: A multi-center retrospective study

被引：0
|
作者：
Sun, H. [1 ,2 ]
Ge, Y. [1 ]
Wu, J. [1 ]
Sun, Y. [1 ]
Zhang, J. [1 ]
Cheng, Q. [1 ]
Wang, D. [1 ]
Wang, X. [1 ]
Li, J. [1 ]
Fu, X. [2 ]
Sun, H. [1 ,2 ]
Gao, A. [2 ]
机构：
[1] Shandong First Med Univ, Phase Clin Res Ctr 1, Canc Hosp, Jinan, Peoples R China
[2] Shandong First Med Univ, Dept Thorac Radiat Oncol, Canc Hosp, Jinan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2420
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1387P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer
    Chang, Myung Hee
    Kim, Kyoung Ha
    Jun, Hyun Jung
    Kim, Hyo Song
    Yi, Seong Yoon
    Uhm, Ji Eun
    Park, Min Jae
    Lim, Do Hyoung
    Ji, Sang Hoon
    Hwang, In Gyu
    Lee, Jeeyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Ahn, Myung-ju
    Park, Keunchil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (05) : 917 - 924
  • [42] Exploration of efficacy of the first-line treatment for advanced non-small cell lung cancer with primary MET-amplification: Retrospective evaluation of 36 cases
    Ding, Kaibo
    Liu, Dujiang
    Jin, Xuanhong
    Xu, Yanjun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [43] Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer
    Myung Hee Chang
    Kyoung Ha Kim
    Hyun Jung Jun
    Hyo Song Kim
    Seong Yoon Yi
    Ji Eun Uhm
    Min Jae Park
    Do Hyoung Lim
    Sang Hoon Ji
    In Gyu Hwang
    Jeeyun Lee
    Yeon Hee Park
    Jin Seok Ahn
    Myung-ju Ahn
    Keunchil Park
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 917 - 924
  • [44] Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer
    Aoki, Takuya
    Ebihara, Akinori
    Yogo, Yurika
    Suemasu, Keiichi
    Sakamaki, Fumio
    ONCOLOGY LETTERS, 2014, 7 (06) : 1771 - 1777
  • [45] Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer
    Piacentini, Paolo
    Greco, Filippo
    Mercanti, Anna
    Trolese, Anna Rita
    Durante, Emilia
    Moratello, Giacomo
    Tognetto, Michele
    Furini, Lara
    Giuliani, Jacopo
    Bonetti, Andrea
    TUMORI JOURNAL, 2013, 99 (06): : 650 - 655
  • [46] First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer A Systematic Review
    Goffin, John
    Lacchetti, Christina
    Ellis, Peter M.
    Ung, Yee C.
    Evans, William K.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 260 - 274
  • [47] Rh-endostatin plus camrelizumab and chemotherapy in first-line treatment of advanced non-small cell lung cancer: A multicenter retrospective study
    Pu, Xingxiang
    Wang, QianZhi
    Liu, Liyu
    Chen, Bolin
    Li, Kang
    Zhou, Yu
    Sheng, Zengmei
    Liu, Ping
    Tang, Yucheng
    Xu, Li
    Li, Jia
    Kong, Yi
    Xu, Fang
    Xu, Yan
    Wu, Lin
    CANCER MEDICINE, 2023, 12 (07): : 7724 - 7733
  • [48] Comparative efficacy of six programmed cell death protein-1 inhibitors in first-line treatment for advanced non-small cell lung cancer: A retrospective cohort study
    Chen, Siyuan
    Qin, Yuhui
    Du, Zhijuan
    Qiao, Yu
    Hu, Yi
    Liu, Zhefeng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Second-line treatment options in advanced non-small cell lung cancer
    de Marinis, Filippo
    Ricciardi, Serena
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S258 - S271
  • [50] Patterns of failure and the subsequent treatment after progression on first-line immunotherapy monotherapy in advanced non-small cell lung cancer: a retrospective study
    Deng, Jia-Yi
    Yang, Ming-Yi
    Yang, Xiao-Rong
    Chen, Zhi-Hong
    Xu, Chong-Rui
    Zhou, Qing
    BMC CANCER, 2024, 24 (01)
12345